The partial reversal of the transdifferentiation program corresponds to our findings that luminal epithelial cells gave rise to claudin-low tumors in the oncogenic KRAS-driven, triple-negative breast cancer model. This evidence concerns the gene KRAS and triple-negative breast carcinoma.